L'Hospitalet de Llobregat, Spain

Jaime Pascual Avellana

This inventor holds 1 USPTO granted patent. Top assignee: Laboratorios Menarini S.a.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jaime Pascual Avellana. Retrieved from https://idiyas.com/inventor/jaime-pascual-avellana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jaime Pascual Avellana: Innovator in Benzopyran Derivatives

Introduction

Jaime Pascual Avellana is a notable inventor based in L'Hospitalet de Llobregat, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of benzopyran derivatives. Her work focuses on compounds that exhibit leukotriene-antagonistic action, which can have important implications for treating various medical conditions.

Latest Patents

Jaime holds a patent for her innovative work titled "Benzopyran derivatives having leukotriene-antagonistic action." This patent represents her commitment to advancing medical science and improving therapeutic options for patients.

Career Highlights

Jaime is currently employed at Laboratorios Menarini S.A., a well-respected company in the pharmaceutical industry. Her role at the company allows her to further her research and development efforts in creating effective medical solutions.

Collaborations

Throughout her career, Jaime has collaborated with esteemed colleagues, including Germano Carganico and David Mauleon Casellas. These partnerships have enriched her research and contributed to the success of her projects.

Conclusion

Jaime Pascual Avellana is a pioneering inventor whose work in benzopyran derivatives showcases her dedication to medical innovation. Her contributions are vital in the ongoing quest for effective treatments in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…